GCG and obesity due to melanocortin 4 receptor deficiency: Incretin biology has become increasingly central to modern metabolic therapeutics, reshaping not only how glucose regulation is understood but also how obesity, cardiovascular disease, and multisystem metabolic dysfunction are treated.